Cargando…

P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.

Detalles Bibliográficos
Autores principales: Summers, Kim, Agrippa, Orlando, Anie, Kofi, Telfer, Paul, Lugthart, Sanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430444/
http://dx.doi.org/10.1097/01.HS9.0000972648.25264.f3
_version_ 1785090965581594624
author Summers, Kim
Agrippa, Orlando
Anie, Kofi
Telfer, Paul
Lugthart, Sanne
author_facet Summers, Kim
Agrippa, Orlando
Anie, Kofi
Telfer, Paul
Lugthart, Sanne
author_sort Summers, Kim
collection PubMed
description
format Online
Article
Text
id pubmed-10430444
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104304442023-08-17 P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE. Summers, Kim Agrippa, Orlando Anie, Kofi Telfer, Paul Lugthart, Sanne Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430444/ http://dx.doi.org/10.1097/01.HS9.0000972648.25264.f3 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Summers, Kim
Agrippa, Orlando
Anie, Kofi
Telfer, Paul
Lugthart, Sanne
P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
title P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
title_full P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
title_fullStr P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
title_full_unstemmed P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
title_short P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
title_sort p1441: real-world outcomes and digitally monitored quality of life in crizanlizumab-treated patients with sickle cell disease.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430444/
http://dx.doi.org/10.1097/01.HS9.0000972648.25264.f3
work_keys_str_mv AT summerskim p1441realworldoutcomesanddigitallymonitoredqualityoflifeincrizanlizumabtreatedpatientswithsicklecelldisease
AT agrippaorlando p1441realworldoutcomesanddigitallymonitoredqualityoflifeincrizanlizumabtreatedpatientswithsicklecelldisease
AT aniekofi p1441realworldoutcomesanddigitallymonitoredqualityoflifeincrizanlizumabtreatedpatientswithsicklecelldisease
AT telferpaul p1441realworldoutcomesanddigitallymonitoredqualityoflifeincrizanlizumabtreatedpatientswithsicklecelldisease
AT lugthartsanne p1441realworldoutcomesanddigitallymonitoredqualityoflifeincrizanlizumabtreatedpatientswithsicklecelldisease